|
|
Analysis of related risk factors of hypertensive nephropathy in the elderly#br# |
HUANG Huacui KE Xiao XIE Guangsu LIU Liping |
Department of Medical Laboratory Medicine, People’s Hospital of Xindu District, Sichuan Province, Chengdu 610500, China |
|
|
Abstract Objective To study the risk-related factors of elderly hypertensive nephropathy in Xindu District, and further provide basis for the early prevention and treatment of elderly hypertensive nephropathy. Methods Elderly hypertensive patients admitted to the People’s Hospital of Xindu District were selected from January 2018 to December 2019. Combined with clinical diagnosis and laboratory examinations, a total of 93 patients with hypertensive nephropathy were established as the study group, while a total of 93 patients with simple hypertension as the control group. The levels of items such as liver function, kidney function, and blood lipids in the serum of the two groups were detected and compared. Multivariate logistic regression analysis was used to evaluate the influencing factors of elderly hypertensive nephropathy. Results Glucose (Glu), triglycerides (TG), cystatin C (CysC), homocysteine (Hcy), urea, creatinine (Cr), and uric acid (UA) in the study group were higher than those in the control group, while high-density lipoprotein cholesterol (HDL-C) and low-density protein cholesterol (LDL-C) were lower than those in the control group, and the differences were statistically significant (P < 0.05). Urea, Cr, UA, HDL-C, TG, CysC, and Hcy were correlated with elderly hypertensive nephropathy (P < 0.05). TG, CysC, and Hcy were the influencing factors of hypertensive nephropathy (P < 0.05). The incidence of hypertensive nephropathy in patients with high TG, CysC, and Hcy were 60.128, 58.486 and 0.897 times of those with simple hypertension, respectively. Conclusion Increases in serum TG, CysC, and Hcy in elderly hypertensive patients are related factors for hypertensive kidney damage. Elderly hypertensive patients should be paid great attention, regular physical examinations to monitor changes in serum indicators, and timely intervention measures should be taken.
|
|
|
|
|
[1] Sule S,Tekin A,Yunus E,et al. Changers in hypeitension prevalence,awareness,treatment,and control rates in Turkey from 2003 to 2012 [J]. J Hypeitens,2016,34(6):1208-1217.
[2] Wang Z,Chen Z,Zhang L,et al. Status of hypeitension in Chinna:results from the China hypeitension survey,2012-2015 [J]. Cirulation,2018,137(22):344-2356.
[3] 《中国高血压防治指南》修订委员会.中国高血压防治指南(2018年修订版)[J].临床医学研究与实践,2019,4(5):201.
[4] 李苏宁,陈祚,王增武,等.我国老年人高血压现状分析[J].中华高血压杂志,2019,27(2):140-148.
[5] WS/T 404.5-2015,临床常用生化检验项目参考区间第5部分:血清尿素、肌酐[S].http://www.nssi.org.cn/nssi/front/87846713.html.
[6] 陈涛,李卫,王杨,等.高尿酸血症的患病情况及相关因素分析[J].中华临床医师杂志:电子版,2012,6(13):49-52.
[7] 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[M].北京:人民卫生出版社,2007:390-409.
[8] 李萌,刘莹,王双,等.成都市体检人群连续8年血尿酸水平变化及高尿酸血症患病率分析[J].中医临床研究,2018,10(34):1-5.
[9] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.
[10] 窦娟,姚武位,徐新献,等.血尿素氮、血肌酐、血清胱抑素C及24 h动态脉压对老年高血压患者早期肾损害的临床评价[J].现代医药卫生,2019,35(22):3462-3464.
[11] 荆一鹏,张可帅,董玉书.血清LDL-C水平在老年男性高血压性脑出血血肿扩大预测中的作用[J].海南医学院学报,2016,22(2):203-205,208.
[12] 常丽花,梁婉琪,李艳川,等.血清Cys C、KIM-1、β2-MG对妊娠期高血压疾病患者肾损伤的诊断价值[J].中国计划生育学杂志,2021,29(2):336-339,425.
[13] 林海龙,谢燕文,梁换仪,等.尿微量白蛋白、血清糖化血红蛋白和血清胱抑素C联合检测在糖尿病肾病早期诊断中的临床价值[J].黑龙江医药,2021,34(1):221-223.
[14] 宫辉,高玲娟,陈亚军.血清Hcy、RBP和Cys C联合检测在妊娠期糖尿病肾病的早期诊断价值[J].国际检验医学杂志,2021,42(3):356-359.
[15] 陈素萍.血清胱抑素C和尿液肾损伤分子-1检测对妊娠期高血压疾病患者早期肾损伤的诊断价值[J].中国妇幼保健,2021,36(3):555-557.
[16] 刘宋芳,王述进,左红,等.胱抑素C在2型糖尿病患者早期肾病中的诊断价值[J].临床医学研究与实践,2021, 6(3):36-39.
[17] 邹健,张艺,翟佳佳,等.甘油三酯和高密度脂蛋白比值与糖尿病肾病的相关性[J].中国慢性病预防与控制,2017, 25(3):184-189.
[18] 刘海波,许建秦,李春梦,等.胱抑素C和甘油三酯检测对糖尿病肾病的早期诊断价值研究[J].陕西医学杂志,2021,50(1):96-99.
[19] 安园.肾功能正常糖尿病患者血脂生化检测的临床价值[J].当代医学,2021,27(1):60-62.
[20] 李隽,张莹,倪会芳,等.甘油三酯-葡萄糖指数与2型糖尿病肾病的相关性[J].河南医学研究,2021,30(2):216-219.
[21] David F,Arnaud C,Fred P. Homocysteine as a risk factor for cardiovascular disease:should we (still) worry about it [J]. Swiss Med Wkly,2006,136(47/48):745-756.
[22] 刘旭帮,魏娟玲.高血压合并冠心病患者同型半胱氨酸与炎性细胞因子水平及意义[J].慢性病学杂志,2021, 22(3):441-442,445.
[23] 孟宪涛,刘久磊,梁庆伟,等.LP-PLA2、sdLDL-C、Hcy在冠心病中医证型中的临床价值及其与冠脉病变程度的相关性[J].中国现代医生,2020,58(4):144-148.
[24] 田烜,王丽丽,赵青,等.Hcy、TIMP-1、CCCK-18与高血压性脑出血病情及预后的相关性分析[J].国际检验医学杂志,2021,42(3):309-311,316.
[25] 范利娜.老年痴呆患者miR-26b、βAPP及Hcy的表达及临床意义[J].四川解剖学杂志,2021,29(1):109-110.
[26] 何月敬,叶敏南,梁丽云,等.冠状动脉疾病与血清Hcy、叶酸及维生素B12水平的相关性[J].中国医药科学,2020,10(3):158-161.
[27] 赵营,翁军,马英,等.高血压合并OSAHS患者PSG与血清ET-1、NO、Hcy、LP及CRP水平的相关性研究[J].中国医药导报,2021,18(13):93-95,99.
[28] 陈志敏,高红兰,左月媛.心脑血管疾病住院患者血清同型半胱氨酸水平分布及意义[J].慢性病学杂志,2021,22(3):339-342. |
|
|
|